化学療法の世界市場レポート 2025

化学療法市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.3％で622億2,000万米ドルに成長します。予測期間の成長は、免疫療法の統合、バイオシミラーの採用、新興市場の成長、ゲノム・プロファイリング、支持療法の進歩、規制の促進などに起因すると考えられます。予測期間の主な動向には、デジタルヘルスソリューション、個別化医療、継続的な腫瘍学研究、人工知能（AI）の統合、ナノテクノロジーの進歩、在宅投与などが含まれます。

予想されるがん罹患率の上昇が化学療法市場の成長を促進します。制御不能な細胞増殖と播種を特徴とするがんでは、急速に増殖するがん細胞を排除するために、強力な化学物質を併用または個別に使用する必要があります。がん罹患率の増加は、化学療法の需要を増大させると予想されます。例えば、米国がん協会（American Cancer Society Inc.）の予測によれば、2023年には米国で新たに190万人のがん患者が発生すると予想されており、2020年に診断された180万人から増加しています。2023年のがん関連死亡者数は609,820人で、2020年の606,520人から増加しています。その結果、がん有病率の上昇が化学療法市場の原動力となっています。

ヘルスケア支出の増加が見込まれることから、化学療法市場の今後の成長が期待されます。ヘルスケア支出は、医療用品、個人的ヘルスケア、長期ケア、公衆衛生サービスを含むヘルスケア商品およびサービスに対する総支出を包含します。ヘルスケア支出は、ヘルスケアサービスを提供するために必要なリソースを提供することで、ヘルスケアシステムにおいて重要な役割を果たしています。ヘルスケア支出の増加は、化学療法に関連するソリューションやサービスの成長を促進し、医療施設や先進治療へのアクセスを向上させる。例えば、2023年10月、米国を拠点に米国の医療システムのパフォーマンスを監視するプラットフォームであるPeterson-KFF Health System Trackerは、2025年には医療支出の伸びが経済を若干上回り、GDPの約17.9%に達すると予測されると報告しました。この動向は今後も続くと予想され、医療費の伸びは経済全体の伸びを上回り、最終的には2032年までにGDPの19.7％に達する可能性が高いです。その結果、ヘルスケア支出の増加が化学療法市場拡大の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界化学療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の化学療法市場：成長率分析
• 世界の化学療法市場の実績：規模と成長, 2019-2024
• 世界の化学療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界化学療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の化学療法市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポンプ
• カニューレ
• カテーテル
• その他の製品タイプ
• 世界の化学療法市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液がん
• 咽頭がん
• 肺がん
• 卵巣がん
• 胃がん
• 世界の化学療法市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルキル化剤
• 代謝拮抗物質
• 抗腫瘍抗生物質
• トポイソメラーゼ阻害剤
• 有糸分裂阻害剤
• その他の薬物
• 世界の化学療法市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• 世界の化学療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 調査機関
• その他のエンドユーザー
• 世界の化学療法市場、ポンプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 輸液ポンプ
• ポータブルポンプ
• 歩行用ポンプ
• 世界の化学療法市場、カニューレのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 末梢カニューレ
• 中心静脈カテーテル
• 埋め込み型ポート
• 世界の化学療法市場、カテーテルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法カテーテル
• PICCライン
• 世界の化学療法市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 安全装置
• IVセット
• 管理セット

第7章 地域別・国別分析

• 世界の化学療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の化学療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 化学療法市場：競合情勢
• 化学療法市場：企業プロファイル
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck & Co Inc.
• Sanofi SA
• Celgene Corporation
• Bristol-Myers Squibb Company
• Amgen Inc.
• Bayer AG
• Almatic Pharma LLC
• AstraZeneca Pharmaceuticals
• Astellas Pharma Inc.
• Puma Biotechnology Inc.
• Clovis Oncology Inc.
• Takeda Pharmaceutical Company Limited
• Johnson & Johnson Services Inc.
• Mylan NV
• Teva Pharmaceutical Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 化学療法市場2029：新たな機会を提供する国
• 化学療法市場2029：新たな機会を提供するセグメント
• 化学療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chemotherapy is a treatment method that employs powerful drugs or medications to target and eliminate fast-growing cells in the body. These drugs are instrumental in killing cancer cells, which proliferate at an accelerated rate. Chemotherapy can involve using drugs individually or in combination to effectively treat various types of cancer.

The primary product types associated with chemotherapy include pumps, cannulas, catheters, and other related equipment. Chemotherapy infusion pumps are devices attached to the patient, delivering controlled doses of drugs gradually into the bloodstream. Services related to chemotherapy encompass treatments for specific types of cancer, such as blood cancer, throat cancer, lung cancer, ovarian cancer, stomach cancer, among others. These treatments typically involve a range of drugs including alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and other medications administered through oral and intravenous routes. Chemotherapy services are primarily utilized by hospitals, research institutes, and other related healthcare facilities.

The chemotherapy market research report is one of a series of new reports from The Business Research Company that provides chemotherapy optical components market statistics, including chemotherapy optical components industry global market size, regional shares, competitors with a chemotherapy optical components market share, detailed chemotherapy optical components market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy optical components industry. This chemotherapy optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chemotherapy market size has grown rapidly in recent years. It will grow from $34 billion in 2024 to $37.78 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to cancer incidence increase, advancements in cancer diagnosis, innovation in drug development, clinical trial activity, access to healthcare, awareness campaigns.

The chemotherapy market size is expected to see rapid growth in the next few years. It will grow to $62.22 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to immunotherapy integration, biosimilar adoption, emerging markets growth, genomic profiling, supportive care advances, regulatory facilitation. Major trends in the forecast period include digital health solutions, personalized medicine, continued oncology research, integration of artificial intelligence (ai), advancements in nanotechnology, home-based chemotherapy administration.

The anticipated rise in cancer prevalence is poised to drive growth in the chemotherapy market. Cancer, characterized by uncontrolled cell growth and dissemination, necessitates the use of potent chemicals, either in combination or individually, to eliminate rapidly proliferating cancer cells. The escalating incidence of cancer is expected to amplify the demand for chemotherapy. For instance, projections from the American Cancer Society Inc. indicate an expected 1.9 million new cancer cases in the US in 2023, marking an increase from 1.8 million cases diagnosed in 2020. The corresponding forecast for cancer-related deaths in 2023 is 609,820, compared to 606,520 in 2020. Consequently, the rising prevalence of cancer is a driving force in the chemotherapy market.

The anticipated rise in healthcare spending is expected to boost the growth of the chemotherapy market in the future. Healthcare spending encompasses the total expenditure on healthcare goods and services, including medical supplies, personal healthcare, long-term care, and public health services. It plays a crucial role in healthcare systems by providing the necessary resources for delivering healthcare services. An increase in healthcare spending fosters the growth of chemotherapy-related solutions and services, enhancing access to medical facilities and advanced treatments. For instance, in October 2023, the Peterson-KFF Health System Tracker, a US-based platform that monitors the U.S. health system's performance, reported that health spending is projected to grow slightly faster than the economy in 2025, reaching approximately 17.9% of GDP. This trend is expected to persist, with health spending growth likely to exceed overall economic growth, ultimately reaching 19.7% of GDP by 2032. Consequently, the rise in healthcare spending is a driving force behind the expansion of the chemotherapy market.

Leading players in the chemotherapy market are strategically concentrating on the introduction of innovative solutions, such as chemotherapy infusion pumps, to establish a competitive advantage. Chemotherapy infusion pumps are devices designed to deliver chemotherapy drugs directly into the bloodstream through an IV line. These pumps enable controlled administration, ensuring a gradual and steady infusion of drugs into the body. A case in point is Shanghai MicroPort Lifesciences Co. Ltd., a China-based medical technology developer and manufacturer, which unveiled AutoEx, its independently developed chemotherapy infusion pump, in March 2022. In clinical applications, specialized infusion pumps are frequently employed for precise and continuous infusion to maintain optimal blood medication concentration during chemotherapy, enhancing anti-cancer cell activity while mitigating side effects. AutoEx, designed for intravenous medication administration, serves the purpose of flushing or sealing PICCs, CVCs, and ports during chemotherapy, offering both intermittent and continuous usage options.

Major players in the chemotherapy market are actively pursuing strategic partnerships as a key avenue to facilitate the commercialization of cutting-edge medical devices aimed at enhancing chemotherapy services. These collaborative ventures are designed to capitalize on the unique strengths and resources of each partner, expediting advancements in cancer treatment, elevating patient outcomes, and addressing unmet medical needs. A notable example occurred in March 2023 when EVERSANA, a US-based provider of global services to the life sciences industry, joined forces with ChemoMouthpiece LLC, a US-based medical device company. This collaboration was forged to support the launch and commercialization of the Chemo Mouthpiece, an innovative intraoral ice pack delivering cryotherapy to the oral cavity of chemotherapy patients. The device plays a crucial role in preventing and treating oral mucositis, a prevalent and painful side effect of chemotherapy.

In February 2024, AbbVie, a global biopharmaceutical company based in the US, completed its acquisition of ImmunoGen for $10.1 billion. This acquisition is anticipated to strengthen AbbVie's oncology portfolio by incorporating ImmunoGen's cutting-edge antibody-drug conjugate technology. With this strategic initiative, AbbVie seeks to enhance its ability to develop advanced treatments for patients fighting different types of cancer. ImmunoGen is also a US-based company focused on the development of chemotherapy drugs.

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chemotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemotherapy market includes revenues earned by entities by providing corticosteroids and hormonal agents as chemotherapy drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chemotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chemotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chemotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Pump; Cannula; Catheter; Other Product Types
• 2) By Service: Blood Cancer; Throat Cancer; Lung Cancer; Ovarian Cancer; Stomach Cancer
• 3) By Drugs: Alkylating Agents; Antimetabolites; Anti-Tumor Antibiotics; Topoisomerase Inhibitors; Mitotic Inhibitors; Other Drugs
• 4) By Route Of Administration: Oral; Intravenous
• 5) By End User: Hospitals; Research Institutes; Other End Users
• Subsegments:
• 1) By Pump: Infusion Pumps; Portable Pumps; Ambulatory Pumps
• 2) By Cannula: Peripheral Cannulas; Central Venous Catheters; Implantable Ports
• 3) By Catheter: Chemotherapy Catheters; PICC Lines
• 4) By Other Product Types: Safety Devices; IV Sets; Administration Sets
• Companies Mentioned: GlaxoSmithKline plc; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Novartis AG; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chemotherapy Market Characteristics

3. Chemotherapy Market Trends And Strategies

4. Chemotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Chemotherapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chemotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chemotherapy Market Growth Rate Analysis
• 5.4. Global Chemotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chemotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chemotherapy Total Addressable Market (TAM)

6. Chemotherapy Market Segmentation

• 6.1. Global Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pump
• Cannula
• Catheter
• Other Product Types
• 6.2. Global Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Cancer
• Throat Cancer
• Lung Cancer
• Ovarian Cancer
• Stomach Cancer
• 6.3. Global Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anti-Tumor Antibiotics
• Topoisomerase Inhibitors
• Mitotic Inhibitors
• Other Drugs
• 6.4. Global Chemotherapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• 6.5. Global Chemotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Other End Users
• 6.6. Global Chemotherapy Market, Sub-Segmentation Of Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infusion Pumps
• Portable Pumps
• Ambulatory Pumps
• 6.7. Global Chemotherapy Market, Sub-Segmentation Of Cannula, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Cannulas
• Central Venous Catheters
• Implantable Ports
• 6.8. Global Chemotherapy Market, Sub-Segmentation Of Catheter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy Catheters
• PICC Lines
• 6.9. Global Chemotherapy Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Safety Devices
• IV Sets
• Administration Sets

7. Chemotherapy Market Regional And Country Analysis

• 7.1. Global Chemotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chemotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chemotherapy Market

• 8.1. Asia-Pacific Chemotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chemotherapy Market

• 9.1. China Chemotherapy Market Overview
• 9.2. China Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chemotherapy Market

• 10.1. India Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chemotherapy Market

• 11.1. Japan Chemotherapy Market Overview
• 11.2. Japan Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chemotherapy Market

• 12.1. Australia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chemotherapy Market

• 13.1. Indonesia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chemotherapy Market

• 14.1. South Korea Chemotherapy Market Overview
• 14.2. South Korea Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chemotherapy Market

• 15.1. Western Europe Chemotherapy Market Overview
• 15.2. Western Europe Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chemotherapy Market

• 16.1. UK Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chemotherapy Market

• 17.1. Germany Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chemotherapy Market

• 18.1. France Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chemotherapy Market

• 19.1. Italy Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chemotherapy Market

• 20.1. Spain Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chemotherapy Market

• 21.1. Eastern Europe Chemotherapy Market Overview
• 21.2. Eastern Europe Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chemotherapy Market

• 22.1. Russia Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chemotherapy Market

• 23.1. North America Chemotherapy Market Overview
• 23.2. North America Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chemotherapy Market

• 24.1. USA Chemotherapy Market Overview
• 24.2. USA Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chemotherapy Market

• 25.1. Canada Chemotherapy Market Overview
• 25.2. Canada Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chemotherapy Market

• 26.1. South America Chemotherapy Market Overview
• 26.2. South America Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chemotherapy Market

• 27.1. Brazil Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chemotherapy Market

• 28.1. Middle East Chemotherapy Market Overview
• 28.2. Middle East Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chemotherapy Market

• 29.1. Africa Chemotherapy Market Overview
• 29.2. Africa Chemotherapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chemotherapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chemotherapy Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chemotherapy Market Competitive Landscape And Company Profiles

• 30.1. Chemotherapy Market Competitive Landscape
• 30.2. Chemotherapy Market Company Profiles
  • 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Chemotherapy Market Other Major And Innovative Companies

• 31.1. Merck & Co Inc.
• 31.2. Sanofi SA
• 31.3. Celgene Corporation
• 31.4. Bristol-Myers Squibb Company
• 31.5. Amgen Inc.
• 31.6. Bayer AG
• 31.7. Almatic Pharma LLC
• 31.8. AstraZeneca Pharmaceuticals
• 31.9. Astellas Pharma Inc.
• 31.10. Puma Biotechnology Inc.
• 31.11. Clovis Oncology Inc.
• 31.12. Takeda Pharmaceutical Company Limited
• 31.13. Johnson & Johnson Services Inc.
• 31.14. Mylan NV
• 31.15. Teva Pharmaceutical Industries Ltd.

32. Global Chemotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chemotherapy Market

34. Recent Developments In The Chemotherapy Market

35. Chemotherapy Market High Potential Countries, Segments and Strategies

• 35.1 Chemotherapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chemotherapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chemotherapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer